BioCentury | Sep 5, 2016
Clinical News

DRX-065: Phase Ia started

...from the 2 cohorts, a third cohort of 6 volunteers will receive 7.5 mg DRX-065. DeuteRx...
...to reference data on safety and efficacy from the scientific literature or previously approved products. DeuteRx LLC...
BioCentury | Oct 5, 2015
Financial News

DeuteRx completes venture financing

...Neurology, Hepatic Date completed: 2015-09-30 Type: Venture financing Raised: $2.2 million Investor: Angel investors Note: DeuteRx...
BioCentury | Apr 9, 2015
Distillery Therapeutics

Therapeutics: An undetermined target

...published online Mar. 9, 2015 doi:10.1073/pnas.1417832112 CONTACT: Sheila H. DeWitt, DeuteRx LLC , Andover, Mass. e-mail: sdewitt@deuterx.com BC...
BioCentury | Apr 2, 2015
Translation in Brief

Mirror, mirror

...is acidic, which results in rapid interconversion of the two forms under physiological conditions. The DeuteRx...
...In the same model, 1.5 mg/kg (+)D2 increased tumor volume compared with vehicle. DeWitt said DeuteRx...
...applications for at least 11 families of deuterated-thalidomide analogs, including analogs of CC-122. Dewitt said DeuteRx...
Items per page:
1 - 4 of 4
BioCentury | Sep 5, 2016
Clinical News

DRX-065: Phase Ia started

...from the 2 cohorts, a third cohort of 6 volunteers will receive 7.5 mg DRX-065. DeuteRx...
...to reference data on safety and efficacy from the scientific literature or previously approved products. DeuteRx LLC...
BioCentury | Oct 5, 2015
Financial News

DeuteRx completes venture financing

...Neurology, Hepatic Date completed: 2015-09-30 Type: Venture financing Raised: $2.2 million Investor: Angel investors Note: DeuteRx...
BioCentury | Apr 9, 2015
Distillery Therapeutics

Therapeutics: An undetermined target

...published online Mar. 9, 2015 doi:10.1073/pnas.1417832112 CONTACT: Sheila H. DeWitt, DeuteRx LLC , Andover, Mass. e-mail: sdewitt@deuterx.com BC...
BioCentury | Apr 2, 2015
Translation in Brief

Mirror, mirror

...is acidic, which results in rapid interconversion of the two forms under physiological conditions. The DeuteRx...
...In the same model, 1.5 mg/kg (+)D2 increased tumor volume compared with vehicle. DeWitt said DeuteRx...
...applications for at least 11 families of deuterated-thalidomide analogs, including analogs of CC-122. Dewitt said DeuteRx...
Items per page:
1 - 4 of 4